CFG
40
8
CF
60
3
MCHP
49
7
HES
62
3
A
46
3
PWR
67
7
ADI
61
5
KMI
57
-2
HRL
35
-3
EQT
50
6
AEP
56
-3
EQIX
62
3
KIM
57
6
JPM
55
2
KLAC
63
7
VTR
47
-8
WEC
43
-3
STT
56
5
CVX
40
2
AVGO
49
9
CFG
40
8
CF
60
3
MCHP
49
7
HES
62
3
A
46
3
PWR
67
7
ADI
61
5
KMI
57
-2
HRL
35
-3
EQT
50
6
AEP
56
-3
EQIX
62
3
KIM
57
6
JPM
55
2
KLAC
63
7
VTR
47
-8
WEC
43
-3
STT
56
5
CVX
40
2
AVGO
49
9
Financhill
Back

Keros Therapeutics Stock Predictions

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
35

KROS
Keros Therapeutics

Last Price:
55.82
Seasonality Move:
37.33%

7 Day Trial

ALL ACCESS PASS

$ 7

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Keros Therapeutics Stock Forecast

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 7.3% based on the past 4 years of stock performance.
  • Keros Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Keros Therapeutics Stock Undervalued?
    The current Keros Therapeutics [KROS] share price is $57.32. The Score for KROS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 7.3% based on the past 4 years of stock performance.

Keros Therapeutics Stock Rating

Sell
35
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics overpriced?

  • Keros Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Keros Therapeutics Stock Price History

Is KROS stock going to rise?

  • The current trend is moderately bullish and KROS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com

52-Week Data

52-Week High:
73.00
52-Week Low:
27.02

Prediction Charts

Market Cap:
2.15B
Price in USD:
57.32
Volume:
361.39K
Beta:
1.12

Technical Analysis

SMA50:
49.36
SMA100:
49.53
SMA200:
52.15
52-Wk Change:
63.07%

Stock Predictions

  • Is Keros Therapeutics stock public?
    Yes, Keros Therapeutics is a publicly traded company.
  • What is the Keros Therapeutics stock quote today?
    The Keros Therapeutics stock price is 57.32 USD today.
  • How to buy Keros Therapeutics stock online?
    You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-30 45.41 45.35 46.65 44.93
Sep-3 45.48 47.79 51.37 45.48
Sep-4 47.70 52.93 54.62 47.70
Sep-5 52.68 53.68 55.01 51.73
Sep-6 53.83 52.48 54.82 51.81
Sep-9 52.54 53.85 55.25 52.54
Sep-10 54.08 54.69 55.25 53.45
Sep-11 54.59 54.75 55.20 53.60
Sep-12 54.50 56.36 56.48 54.07
Sep-13 56.94 56.98 58.36 55.89
Sep-16 57.09 55.62 57.77 55.21
Sep-17 55.68 55.04 55.72 54.60
Sep-18 55.04 55.71 57.08 54.44
Sep-19 57.21 57.32 58.28 56.30

Keros Therapeutics Earnings

Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics Forecast Revenue Growth

Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.31 per share, and a decrease next year of $0.43 per share.

* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.